Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension-Reference-Cited by-同舟云学术

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Published:2013-03-01 Issue:3 Volume:98 Page:1154-1162
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Mathieu Chantal¹,Hollander Priscilla²,Miranda-Palma Bresta³,Cooper John⁴,Franek Edward⁵,Russell-Jones David⁶,Larsen Jens⁷,Tamer Søren Can⁷,Bain Stephen C.⁸,

Affiliation:

1. UZ Gasthuisberg (C.M.), KU Leuven, 3000 Leuven, Belgium

2. Baylor Endocrine Center (P.H.), Dallas, Texas 75246

3. Miller School of Medicine (B.M.-P.), University of Miami, Miami, Florida 33136

4. Department of Medicine (J.C.), Stavanger University Hospital, 4068 Stavanger, Norway

5. Central Clinical Hospital MSWiA and Medical Research Center (E.F.), Polish Academy of Sciences, 02-507 Warsaw, Poland

6. Royal Surrey County Hospital and University of Surrey (D.R.-J.), GU2 7XX Guildford, United Kingdom

7. Novo Nordisk A/S (J.L., S.C.T.), DK-2860 Søborg, Denmark

8. Institute of Life Sciences (S.C.B.), Swansea University, SA2 8QA Swansea, United Kingdom

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/3/1154/20288415/jcem1154.pdf

Reference25 articles.

1. Correlates of insulin injection omission;Peyrot;Diabetes Care,2010

2. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.;Rubin;Am J Med,2005

3. How much do forgotten insulin injections matter to hemoglobin A1c in people with diabetes? A simulation study;Randløv;J Diabetes Sci Techn,2008

4. Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus.;Morris;Lancet,1997

5. Self-reported compliance with insulin injection therapy in subjects with type 1 and type 2 diabetes;Anderson;Diabetes Metab,2003

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable systems for long-lasting insulin therapy;Advanced Drug Delivery Reviews;2023-12

2. Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial;The Lancet;2023-11

3. Treating obesity in type 1 diabetes mellitus – review of efficacy and safety;Current Opinion in Endocrinology, Diabetes & Obesity;2023-10-11

4. Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations;Diabetes Therapy;2023-09-22

5. No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study;Diabetologia;2023-03-07